About API
Active pharmaceutical ingredients (API) are active substances that are used in the manufacture of drugs and that have pharmacological effects. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. API may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology and for treatment of conditions such as respiratory disorders and rheumatoid arthritis.
TechNavio's analysts forecast the API market in the US to grow at a CAGR of 7.01 percent over the period 2014-2019.
Covered in this Report
The report covers the present scenario and the growth prospects of the API market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. It provides the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The market segmentation is carried out on the basis of: type of production process (synthetic production process and biotechnology-based production process), type of product (conventional API and high-potency API), and type of players (captive and merchant).
The report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
TechNavio's report, the API Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.
Key Vendors
• Abbott Laboratories
• Aurobindo Pharma
• Mylan
• Teva Pharmaceutical Industries
Other Prominent Vendors
• Albemarle
• Aptuit
• BASF
• Biocon
• Boehringer Ingelheim
• Cambrex
• Cipla
• Dr. Reddy's Laboratories
• Hospira
• Lonza Group
• Novartis
• Pfizer
• Sigma-Aldrich
• Sun Pharmaceutical Industries
Market Driver
• Strong Preference for Generic Drugs
• For a full, detailed list, view our report
Market Challenge
• Decrease in R&D Spending
• For a full, detailed list, view our report
Market Trend
• Strong Focus on High-potency API
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
07. API Market in the US
07.1 Market Size and Forecast
07.2 Five Forces Analysis
08. Market Segmentation by Type of Production Process
09. Market Segmentation by Type of Product
10. Market Segmentation by Type of Players
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.2 Key Vendors 2014
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Abbott Laboratories Inc.
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Business Segmentation
19.1.4 Business Strategy
19.1.5 Revenue by Business Segmentation
19.1.6 Revenue Comparison 2011 and 2012
19.1.7 Revenue by Geographical Segmentation
19.1.8 Key Information
19.1.9 SWOT Analysis
19.2 Aurobindo Pharma
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation
19.2.4 Geographical Segmentation by Revenue 2014
19.2.5 Business Strategy
19.2.6 Recent Developments
19.2.7 SWOT Analysis
19.3 Mylan
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue 2013
19.3.4 Business Segmentation by Revenue 2011-2013
19.3.5 Geographical Segmentation by Revenue 2013
19.3.6 Business Strategy
19.3.7 Recent Developments
19.3.8 SWOT Analysis
19.4 Teva Pharmaceutical Industries
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation
19.4.4 Business Segmentation by Revenue 2013
19.4.5 Business Segmentation by Revenue 2012 and 2013
19.4.6 Sales by Geography
19.4.7 Business Strategy
19.4.8 Key Developments
19.4.9 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Segmentation of the API Market in US
Exhibit 3: Segmentation of the API Market in US by Type of Production Process
Exhibit 4: Segmentation of the API Market in US by Type of Product
Exhibit 5: Segmentation of the API Market in US by Type of Players
Exhibit 6: API Market in the US 2014-2019 (US$ billion)
Exhibit 7: Segmentation of API Market in US by Technology 2014
Exhibit 8: Segmentation of the API Market in US by Type of Product 2014
Exhibit 9: Segmentation of the API Market in US by Type of Players 2014
Exhibit 10: Small Molecule Drugs: Patent Expiry during 2013-2016
Exhibit 11: Abbott Laboratories Inc.: Business Segmentation
Exhibit 12: Abbott Laboratories Inc.: Revenue by Business Segmentation 2012
Exhibit 13: Abbott Laboratories Inc.: Revenue by Business Segmentation 2011 and 2012 (US$ million)
Exhibit 14: Abbott Laboratories Inc.: Revenue by Geographical Segmentation 2012
Exhibit 15: Aurobindo Pharma: Business Segmentation
Exhibit 16: Aurobindo Pharma: Geographical Segmentation by Revenue 2014
Exhibit 17: Active Pharmaceutical Ingredients (API) Market in the US: Business Segmentation by Revenue 2013
Exhibit 18: Active Pharmaceutical Ingredients (API) Market in the US: Business Segmentation by Revenue 2011-2013 (US$ billion)
Exhibit 19: Active Pharmaceutical Ingredients (API) Market in the US: Geographical Segmentation by Revenue 2013
Exhibit 20: Teva Pharmaceutical Industries: Business Segmentation
Exhibit 21: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2013
Exhibit 22: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 23: Teva Pharmaceutical Industries: Sales by Geography 2013
